Report overview
The global Human Growth Hormone Treatment and Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Powder Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Human Growth Hormone Treatment and Drug include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
This report aims to provide a comprehensive presentation of the global market for Human Growth Hormone Treatment and Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Growth Hormone Treatment and Drug. This report contains market size and forecasts of Human Growth Hormone Treatment and Drug in global, including the following market information:
Global Human Growth Hormone Treatment and Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Human Growth Hormone Treatment and Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Human Growth Hormone Treatment and Drug companies in 2023 (%)
We surveyed the Human Growth Hormone Treatment and Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Growth Hormone Treatment and Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Growth Hormone Treatment and Drug Market Segment Percentages, by Type, 2023 (%)
Powder
Solvent
Global Human Growth Hormone Treatment and Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Growth Hormone Treatment and Drug Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Other
Global Human Growth Hormone Treatment and Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Growth Hormone Treatment and Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Growth Hormone Treatment and Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Human Growth Hormone Treatment and Drug revenues share in global market, 2023 (%)
Key companies Human Growth Hormone Treatment and Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Human Growth Hormone Treatment and Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Anhui Anke Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Growth Hormone Treatment and Drug, market overview.
Chapter 2: Global Human Growth Hormone Treatment and Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Human Growth Hormone Treatment and Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Growth Hormone Treatment and Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Growth Hormone Treatment and Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
